SHANGHAI MEDICILON INC revenue breakdown overview

SHANGHAI MEDICILON INC revenue for the last year amounted to 1.04 B CNY, the most of which — 542.21 M CNY — came from its highest performing source at the moment, Preclinical Research, the year earlier bringing 733.80 M CNY. The greatest contribution to the revenue figure was made by China — last year it brought SHANGHAI MEDICILON INC 643.54 M CNY, and the year before that — 978.16 M CNY.